|
業務類別
|
Drug Manufacturers - Specialty & Generic |
|
業務概覽
|
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulinactive pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue. |
| 公司地址
| 11570 6th Street, Rancho Cucamonga, CA, USA, 91730 |
| 電話號碼
| +1 909 980-9484 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.amphastar.com |
| 員工數量
| 1976 |
| Mr. William J. Peters |
Director, Principal Accounting Officer, Chief Financial Officer, Executive Vice President, Finance and Treasurer; President of International Medication Systems, Limited |
美元 625.53K |
26/02/2026 |
| Dr. Jack Yongfeng Zhang, PhD |
Director, President, Chief Executive Officer and Chief Scientific Officer |
美元 915.31K |
26/02/2026 |
| Dr. Mary Ziping Luo, PhD |
Chairman of the Board, Chief Operating Officer and Chief Scientist |
美元 746.04K |
26/02/2026 |
| Mr. Rong Zhou |
Senior Executive Vice President, Production Center, Executive Vice President, Scientific Affairs; President of Amphastar Nanjing Pharmaceuticals, Co., Ltd. |
美元 564.48K |
14/04/2025 |
| Mr. Jacob Liawatidewi |
Director and Executive Vice President, Sales and Marketing and Corporate Administration Center; President of Amphastar France Pharmaceuticals, S.A.S |
美元 480.79K |
26/02/2026 |
|
|
| Dr. Howard S. Lee, PhD |
Independent Director |
26/02/2026 |
| Mr. Richard Prins |
Lead Independent Director |
26/02/2026 |
| Mr. William J. Peters |
Director, Principal Accounting Officer, Chief Financial Officer, Executive Vice President, Finance and Treasurer; President of International Medication Systems, Limited |
26/02/2026 |
| Mr. David Gaugh |
Independent Director |
26/02/2026 |
| Dr. Jack Yongfeng Zhang, PhD |
Director, President, Chief Executive Officer and Chief Scientific Officer |
26/02/2026 |
| Dr. Mary Ziping Luo, PhD |
Chairman of the Board, Chief Operating Officer and Chief Scientist |
26/02/2026 |
| Dr. Michael A. Zasloff, M.D.,PhD |
Independent Director |
26/02/2026 |
| Mr. Floyd F. Petersen, M.P.H. |
Independent Director |
26/02/2026 |
| Ms. Diane G. Gerst |
Independent Director |
26/02/2026 |
| Mr. Jacob Liawatidewi |
Director and Executive Vice President, Sales and Marketing and Corporate Administration Center; President of Amphastar France Pharmaceuticals, S.A.S |
26/02/2026 |
| Ms. Gayle M. Deflin |
Independent Director |
26/02/2026 |
|
|
|
|
